Talis Biomedical Quote - TLIS | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Talis Biomedical Corporation (TLIS) Share Price

Talis Biomedical Corporation (TLIS)

4.38

0.00

(0.00%)

Closed September 06 3:00PM

Delayed by 15 minutes

4.38

0.00

( 0.00% )

Pre Market: 7:00PM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

4.38

Bid

4.05

Ask

4.49

Volume

-

0.00 Day's Range 0.00

3.42 52 Week Range 9.60

Market Cap

Previous Close

4.38

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

22,769

Shares Outstanding

1,822,820

Dividend Yield

-

PE Ratio

-0.13

Earnings Per Share (EPS)

-34.02

Revenue

2.13M

Net Profit

-62.01M

Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious disease... Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19. Show more

Sector

Lab Analytical Instruments

Industry

Lab Analytical Instruments

Website

talisbio.com

Headquarters

Wilmington, Delaware, USA

Founded

-

Talis Biomedical Corporation is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker TLIS. The last closing price for Talis Biomedical was US$4.38. Over the last year, Talis Biomedical shares have traded in a share price range of US$ 3.42 to US$ 9.60.

Talis Biomedical currently has 1,822,820 shares outstanding. The market capitalization of Talis Biomedical is US$7.98 million. Talis Biomedical has a price to earnings ratio (PE ratio) of -0.13.

Form 8-K - Current report

IBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without Astronauts

International Business Machines (NYSE:IBM) – According to the South China Morning Post, IBM has closed its R&D operations in China, laying off over 1,000 employees due to geopolitical...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash

REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0.63	16.8	3.75	4.89	3.42	32176	4.18271332	CS
12	-4.49	-50.6200676437	8.87	9.35	3.42	22769	5.37921615	CS
26	-3.67	-45.5900621118	8.05	9.6	3.42	14017	6.40888634	CS
52	-1.83	-29.4685990338	6.21	9.6	3.42	13357	6.78908229	CS
156	-111.87	-96.2322580645	116.25	120.75	3.42	99816	28.14387142	CS
260	-430.62	-98.9931034483	435	507.9	3.42	133371	89.49080958	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SINTSiNtx Technologies Inc	US$ 5.36 (90.07%)	7.61M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.2232 (56.63%)	69.93M
INBSIntelligent Bio Solutions Inc	US$ 2.42 (53.16%)	12.72M
SMMTSummit Therapeutics Inc	US$ 16.17 (31.78%)	3.44M
BNRGBrenmiller Energy Ltd	US$ 1.21 (27.37%)	817.42k
PEGYPineapple Energy Inc	US$ 0.53485 (-33.92%)	54.92k
CCBGCapital City Bank Group Inc	US$ 25.09 (-25.77%)	1
FHTXFoghorn Therapeutics Inc	US$ 6.00 (-20.32%)	3
WHLRWheeler Real Estate Investment Trust Inc	US$ 8.30 (-19.02%)	1.13M
NDRAENDRA Life Sciences Inc	US$ 0.2361 (-18.02%)	585.26k
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.2232 (56.63%)	69.93M
INBSIntelligent Bio Solutions Inc	US$ 2.42 (53.16%)	12.72M
IVPInspire Veterinary Partners Inc	US$ 1.1102 (27.24%)	10.48M
BLMZBloomZ Inc	US$ 2.17 (22.60%)	10.43M
WTOUTime Limited	US$ 0.0632 (-4.24%)	8.11M

tradernewstip

tradernewstip 1 minute ago

$AIMD announce that its groundbreaking VELDONA® formulation has been granted an invention patent in Taiwan and has filed for global patent protection under the Patent Cooperation Treaty (PCT). This patent represents a significant milestone in the treatment and prevention of coronavirus infections.

Hosai

Hosai 1 minute ago

"They obviously in the end didn't, now focusing first and it seems exclusively on the hope that EMA might approve."

You realize every company that applies for a new drug application does so "on the hope" that the regulator "might approve"? One can just say - "is submitting an applica

maperatpogi

maperatpogi 1 minute ago

Yikes??? Yes and yes.
The increase in authorized common stock will not have any immediate effect on the rights of existing stockholders, but would have a dilutive effect on our existing stockholders when the additional shares are issued. This increase in the authorized number of shares of co

Implanting

Implanting 1 minute ago

I don't see Dan as inept or worthy of being let-go AT THIS STAGE OF THE GAME. I believe Keith's biggest purpose for him has been to get Springpole permitted and although there have been many timeline set-backs with that endeavor, it's appears it's finally going to get done. My biggest issue with Dan

KISSINGER

KISSINGER 1 minute ago

The contract to my understanding was signed over a year ago but needed to be updated for vast tags fast ads as opposed to just the app. So it's still awaiting signatures on the updated contract and the contract is actually with VIDAA which is the operating system that Hisense produces. Hopefully we'

JusticeWillWin

JusticeWillWin 2 minutes ago

"...making it [COOP] the top servicer over JPMorgan Chase"======>GREAT!!!

timberwolf7

timberwolf7 2 minutes ago

WEF confirming the covid BS was a TEST to
see how many WILLINGLY were braindead?
Given the lack of desire for the TRUTH by
many on here? Many of them are being
described by this one..

Bulldog Breed@Gary3 4h
·Exposing Gates, Fauci, Soros &

nicehit

nicehit 2 minutes ago

I'm just trying to wake things up here. Maybe shake up those in control at NSAV to get this going or get somebody who will!!

limer814

limer814 2 minutes ago

Not sure anyone is listening to your last 5 posts ,but I guess you are the one covering over .24

Stockfire409

Stockfire409 2 minutes ago

"Beta is practice" LOL, no...thats not how Beta software launches work. This probably isn't the stock for you.

Chiron

Chiron 2 minutes ago

No, I was wrong, not even 33s available

mike00h

mike00h 2 minutes ago

The press hasn't heard of DCVax.

https://www.barrons.com/articles/merck-stock-keytruda-summit-cancer-drug-2710d5b5?mod=hp_DAY_Theme_1_1

Singhania

Singhania 2 minutes ago

$OSTX is looking lovely on the chart as the stock has soared over 65% from August and now trading just 15% away from its all-time high of $4.90.

Moreover, the stock is trading well above all the key Moving Averages and signal solid strength. $OSTX has been witnessing increased volume

NewBornTrade

NewBornTrade 3 minutes ago

We understand they need to raise capital - They’ve mentioned it on X - 900M shares issued since may - What we don’t know is if these are toxic debtors issuances or capital raise issuances - Very different things !

I’m not here to be negative nor positive - What I see is what I see -

vein

vein 3 minutes ago

Let’s hope all these board additions show us something!!

Singhania

Singhania 3 minutes ago

$OSTX is looking lovely on the chart as the stock has soared over 65% from August and now trading just 15% away from its all-time high of $4.90.

Moreover, the stock is trading well above all the key Moving Averages and signal solid strength. $OSTX has been witnessing increased volume

Singhania

Singhania 3 minutes ago

$OSTX is looking lovely on the chart as the stock has soared over 65% from August and now trading just 15% away from its all-time high of $4.90.

Moreover, the stock is trading well above all the key Moving Averages and signal solid strength. $OSTX has been witnessing increased volume

mrplmer

mrplmer 3 minutes ago

Chiron

Chiron 3 minutes ago

Mark

Mark 3 minutes ago

$WKHS .70 has FEDEX news, may be a good one today, ww

prototype_101

prototype_101 3 minutes ago

Another POWER HITTER!!! the flood gates are OPENING NOW and it will be an EXTREMELY BAD time to be a SHORT!!!!

Lebby's TIMELINE remains the SAME since 2019 at least!!!! here is a link to the 2019 ASM presentation and Lebby at 27:27 shows the TIMELINE to Customer Acceptance and Ramp,

stockplayer-11

stockplayer-11 3 minutes ago

ASII now increasing the AS from 2.5b to 5b

KCCO7913

KCCO7913 4 minutes ago

You couldn't be more wrong.

trader_ron

trader_ron 4 minutes ago

$SMCE - SMC Entertainment Enters Letter of Intent to Acquire Boutique Investment Manager, Bateau Asset Management, Providing Entry to Australian and Southeast Asian Financial Services Market
https://www.otcmarkets.com/stock/SMCE/news/SMC-Entertainment-Enters-Letter-of

Poo28

Poo28 4 minutes ago

Update No 2- SPECIAL SHAREHOLDER UPDATE No.2 — September 9, 2024

Digital Brand Media & Marketing Group, Inc. (“The Company” and “DBMM”), along with its brand, Digital Clarity (“DC”), a fully integrated management consultancy specializing in the optimal marketing of B2B tech companie

Talis Biomedical

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions